These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6787809)

  • 1. [Failure of antibiotic therapy of epidemic cerebrospinal meningitis].
    Kostrzewski JM
    Wiad Lek; 1980 Dec; 33(23):1923-5. PubMed ID: 6787809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meningococcal meningitis in Spain (1978-1981). III. Susceptibility of the meningococcal strains isolated from patients and carriers to the main agents used in the treatment and chemoprophylaxis of meningococcal infections].
    Sáez Nieto JA; Vázquez J; Casal J
    Rev Sanid Hig Publica (Madr); 1983; 57(5-6):587-602. PubMed ID: 6422536
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic-susceptibility of Neisseria meningitidis in Egypt.
    Mikhail IA; Girgis NI; Farid Z; Haberberger RL; Woody JN
    Trop Geogr Med; 1989 Jul; 41(3):285. PubMed ID: 2512704
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological and clinical data concerning the reaction of Neisseria meningitides A to several sulfonamides and antibiotics: observations at Fort-Lamy (Chad) during a seasonal outbreak of cerebrospinal meningitis].
    Lefèvre M; Sirol J; Vandekerkove M; Faucon R
    Bull World Health Organ; 1969; 40(3):331-42. PubMed ID: 4979619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibioprophylaxis of meningococcal meningitis: reality or utopia? (author's transl)].
    Albert JP; Etienne J
    Med Trop (Mars); 1978; 38(5):501-11. PubMed ID: 106213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current aspects of epidemic cerebrospinal meningitis in Rumania].
    Mihalcu F; Paşolescu O; Coban V; Cuciureanu G; Dumitrescu S
    Arch Roum Pathol Exp Microbiol; 1972 Mar; 31(1):125-33. PubMed ID: 4632611
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bacteriological considerations on epidemic cerebrospinal meningitis].
    Mihalcu F; Paşolescu G; Mermezan E; Cuciureanu G; Dumitrescu S
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):601-7. PubMed ID: 5000095
    [No Abstract]   [Full Text] [Related]  

  • 8. [Failure of chemoprophylaxis due to resistance of Neisseria meningitidis to rifampicin].
    Bordessoule A; Hoppé A; Ringuier B; Giniès JL
    Arch Pediatr; 2007 Jan; 14(1):99-100. PubMed ID: 17145173
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic impact of changing susceptibility of germs causing community-acquired bacterial meningitis in pediatric patients (excluding neonatal period)].
    Doit C; Bingen E
    Ann Med Interne (Paris); 2002 Sep; 153(5):329-37. PubMed ID: 12442079
    [No Abstract]   [Full Text] [Related]  

  • 10. Outbreak of meningitis due to Neisseria meningitidis--a microbiological profile.
    Bhave GG; Gaikwad S
    J Postgrad Med; 1986 Jan; 32(1):24-6. PubMed ID: 3091814
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current status of cerebrospinal meningitis].
    Giannico L
    Minerva Med; 1974 Dec; 65(89):4651-5. PubMed ID: 4215991
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampin-resistant Neisseria meningitidis.
    Taha MK; Zarantonelli ML; Ruckly C; Giorgini D; Alonso JM
    Emerg Infect Dis; 2006 May; 12(5):859-60. PubMed ID: 16710955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiology and therapy of infections caused by Neisseria meningitidis].
    Skoczyńska A; Hryniewicz W
    Pol Merkur Lekarski; 2003 Nov; 15(89):459-62. PubMed ID: 14969144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria meningitidis susceptibility in North-Cameroon.
    Bouba G; Nelly Michèle G; Lombart JP
    Med Mal Infect; 2014 Sep; 44(9):443-4. PubMed ID: 25223793
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid sterilisation of cerebrospinal fluid in meningococcal meningitis: Implications for treatment duration.
    Crosswell JM; Nicholson WR; Lennon DR
    J Paediatr Child Health; 2006 Apr; 42(4):170-3. PubMed ID: 16630316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemic cerebrospinal meningitis and anti-meningococcic vaccination].
    Ivan A; Nastase A
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(1):23-6. PubMed ID: 97747
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulphonamide-susceptibility of meningococci isolated from patients in the Netherlands, before, during and after an epidemic of meningococcal disease.
    Severin WP; Ruys AC; Butter MN; Walig C
    Zentralbl Bakteriol Orig; 1969; 211(2):198-205. PubMed ID: 4989402
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serogroup W135 meningococcal meningitis epidemic in 2000 and 2001].
    Nicolas P
    Med Trop (Mars); 2001; 61(3):259-61. PubMed ID: 11582892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Meningococcal meningitis in Spain (1978-1980). I. Epidemiologic studies, serogroups and sensitivity to antimicrobial agents].
    Sáez Nieto JA; Llacer A; Catalá F; Fenoll A; Casal J
    Rev Sanid Hig Publica (Madr); 1981; 55(7-8):831-69. PubMed ID: 6815776
    [No Abstract]   [Full Text] [Related]  

  • 20. Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain.
    Alcalá B; Salcedo C; de la Fuente L; Arreaza L; Uría MJ; Abad R; Enríquez R; Vázquez JA; Motgé M; de Batlle J
    J Antimicrob Chemother; 2004 Feb; 53(2):409. PubMed ID: 14729735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.